Promoters hold 77.8% of Emcure Pharmaceuticals Limited (EMCURE). FIIs hold 4.9%, mutual funds 6.9% and other DIIs 1.6%. 0.0% of the promoter holding is pledged. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jul 24 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 77.8% | 77.9% | 77.9% | 77.9% | 77.9% | 77.9% | 77.9% | 78.1% | 78.1% |
| FII | 4.9% | 3.4% | 3.6% | 3.3% | 2.9% | 3.1% | 3.0% | 2.9% | 1.8% |
| MF | 6.9% | 4.9% | 4.8% | 3.6% | 2.3% | 2.7% | 3.1% | 3.3% | 1.8% |
| Other DII | 1.6% | 1.2% | 1.3% | 0.8% | 0.5% | 0.7% | 0.8% | 0.7% | 1.6% |
| Retail & others | 8.8% | 12.7% | 12.4% | 14.5% | 16.4% | 15.6% | 15.1% | 15.1% | 16.8% |
| Pledge | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — | — | — |
No PIT or SAST disclosures on record for this stock in the last 12 months.
That is the usual state — promoters, directors and holders above 5% file only when they trade or pledge; a new filing appears here within a day of reaching the exchange.
In Jun 26, FII holding rose +1.5pp and mutual funds +1.9pp, while retail trimmed −3.8pp. Rising institutional ownership is often read as “smart money” accumulation — though it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
